Genmab A/S (GMAB) is currently Overvalued by 304.50%

Genmab A/S (GMAB) appears overvalued by approximately 304.50% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

Downside (live) 304.50% (from live valuation API)
Confidence (live) 8.5/10 (High conviction overvalued)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$28.01

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE Calculator Stock Valuation Calculator

Why is Genmab A/S overvalued or undervalued?

For Genmab A/S, intrinsic value ties fair value to sustainable cash generation; with the stock above that level, the snapshot reads as a premium versus fundamentals rather than a pure sentiment call.

Historical valuation for GMAB shows cycles where multiples expanded and compressed; today’s positioning rhymes more with growth optimism than the mid-range of its recent history.

Market expectations boil down to growth, risk, and return on capital—current levels bake in strong execution, so disappointments hit harder. Cross-check with live ratios when your API is connected.

Key metrics

P/E ratio: 37.5x
Revenue growth (TTM y/y): 28%
Profit margin: 34.5%
Fair value (model): Unlock

Next steps

Frequently asked questions — GMAB

Is GMAB overvalued right now?

Based on our 2026 models, Genmab A/S (GMAB) appears overvalued at $28.01 with roughly 304.5% downside versus fair value. Confirm with valuation ratios and financials before acting.

What is Genmab A/S's intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether GMAB trades above or below fair value. At $28.01, Genmab A/S currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Genmab A/S's intrinsic value calculated?

Tickerplace calculates GMAB's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is GMAB undervalued right now?

A stock is undervalued when price sits below a supportable fair value range. Check whether GMAB's gap aligns with fundamentals using the ratios and financial links on this page.

Peers for GMAB: open their overvalued / undervalued view.

Instant valuation answer